Skip to main content
SpringerLink
Log in

MUW researcher of the month

  • MUW researcher of the month
  • Published:
Wiener klinische Wochenschrift Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Fuchs CD, Paumgartner G, Mlitz V, Kunczer V, Halilbasic E, Leditznig N, Wahlstrom A, et al. Colesevelam attenuates cholestatic liver and bile duct injury in Mdr2(-/-) mice by modulating composition, signalling and excretion of faecal bile acids. Gut. 2018;67:1683–91. IF:17,02.

    Article  CAS  Google Scholar 

  2. Slijepcevic D, Roscam Abbing RLP, Fuchs CD, Haazen LCM, Beuers U, Trauner M, Oude Elferink RPJ, et al. Na(+) -taurocholate cotransporting polypeptide inhibition has hepatoprotective effects in cholestasis in mice. Hepatology. 2018. IF:14,08. https://doi.org/10.1002/hep.29888

    Article  PubMed  PubMed Central  Google Scholar 

  3. Baghdasaryan A, Fuchs CD, Osterreicher CH, Lemberger UJ, Halilbasic E, Pahlman I, Graffner H, et al. Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis. J Hepatol. 2016;64:674–81. IF:15,04.

    Article  CAS  Google Scholar 

  4. Fuchs CD, Paumgartner G, Wahlstrom A, Schwabl P, Reiberger T, Leditznig N, Stojakovic T, et al. Metabolic preconditioning protects BSEP/ABCB11(-/-) mice against cholestatic liver injury. J Hepatol. 2017;66:95–101. IF:15,04.

    Article  CAS  Google Scholar 

  5. Lemberger UJ, Fuchs CD, Schofer C, Bileck A, Gerner C, Stojakovic T, Taketo MM, et al. Hepatocyte specific expression of an oncogenic variant of beta-catenin results in lethal metabolic dysfunction in mice. Oncotarget. 2018;9:11243–57. IF:5,20.

    Article  Google Scholar 

  6. Lemberger UJ, Fuchs CD, Karer M, Haas S, Stojakovic T, Schofer C, Marschall HU, et al. Hepatocyte specific expression of an oncogenic variant of beta-catenin results in cholestatic liver disease. Oncotarget. 2016;7:86985–98. IF:5,20.

    Article  Google Scholar 

  7. Blokker BA, Maijo M, Echeandia M, Galduroz M, Patterson AM, Ten A, Philo M, et al. Fine-tuning of SIRT1 expression is essential to protect the liver from cholestatic liver disease. Hepatology. 2018. IF:14,08. https://doi.org/10.1002/hep.30275

    Article  Google Scholar 

  8. Sombetzki M, Fuchs CD, Fickert P, Osterreicher CH, Mueller M, Claudel T, Loebermann M, et al. 24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis. J Hepatol. 2015;62:871–8. IF:15,04.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinische Abteilung für Gastroenterologie und Hepatologie, Medizinische Universität Wien, Universitätsklinik für Innere Medizin III, Währinger Gürtel 18–20, 1090, Wien, Austria

    Claudia D. Fuchs-Steiner

Authors
  1. Claudia D. Fuchs-Steiner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Claudia D. Fuchs-Steiner.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fuchs-Steiner, C. MUW researcher of the month. Wien Klin Wochenschr 131, 188–189 (2019). https://doi.org/10.1007/s00508-019-1495-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00508-019-1495-4

Search

Navigation